Statement on stem cell clinic permanent injunction and FDA’s ongoing efforts to protect patients from risks of unapproved products - FDA Press Releases

Statement by Acting FDA Commissioner Ned Sharpless, M.D., and Biologics Center Director Peter Marks, M.D., Ph.D. on stem cell clinic permanent injunction and FDA’s ongoing efforts to protect patients from risks of unapproved products

from FDA Press Releases RSS Feed http://bit.ly/2IJKcPo
via IFTTT